{"id":1346,"date":"2022-05-20T09:00:00","date_gmt":"2022-05-20T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/new-product-natulan-obtained-drug-registration-certificate\/"},"modified":"2026-09-24T09:51:08","modified_gmt":"2026-09-24T09:51:08","slug":"new-product-natulan-obtained-drug-registration-certificate","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/new-product-natulan-obtained-drug-registration-certificate\/","title":{"rendered":"New product Natulan\u00ae obtained Drug Registration Certificate"},"content":{"rendered":"<p>Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) is pleased to announce that, the Drug Registration Certificate for in-licensed product Natulan\u00ae (Procarbazine Capsules) has been obtained from the China National Medical Products Administration (\u201cNMPA\u201d). Natulan\u00ae has been approved for use in combination with other anticancer drugs to treat Hodgkin\u2019s Lymphoma (\u201cHL\u201d).<\/p>\n<p class=\"lpns-download-wrap\"><a class=\"lpns-download\" href=\"https:\/\/www.leespharm.com\/wp-content\/uploads\/2022\/07\/20.05.2022-New-product-Natulan-obtained-Drug-Registration-Certificate.pdf\" target=\"_blank\" rel=\"noopener\">\u0e14\u0e32\u0e27\u0e19\u0e4c\u0e42\u0e2b\u0e25\u0e14\u0e02\u0e48\u0e32\u0e27\u0e09\u0e1a\u0e31\u0e1a\u0e40\u0e15\u0e47\u0e21 (PDF)<\/a><\/p>\n<p><em>\u0e17\u0e35\u0e48\u0e21\u0e32: <a href=\"https:\/\/www.leespharm.com\/media\/?filter=Recent\" target=\"_blank\" rel=\"noopener\">Lee&#8217;s Pharmaceutical Holdings \u2013 News &amp; Media<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) is pleased to announce that, the Drug Registration Certificate for in-licensed product Natulan\u00ae (Procarbazine Capsules) has been obtained from the China National Medical Products Administration (\u201cNMPA\u201d). Natulan\u00ae has been approved for use in combination with other anticancer drugs to treat Hodgkin\u2019s Lymphoma (\u201cHL\u201d). \u0e14\u0e32\u0e27\u0e19\u0e4c\u0e42\u0e2b\u0e25\u0e14\u0e02\u0e48\u0e32\u0e27\u0e09\u0e1a\u0e31\u0e1a\u0e40\u0e15\u0e47\u0e21 (PDF) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1347,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,29],"tags":[],"class_list":["post-1346","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lees-pharm-group-news","category-news"],"_links":{"self":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/comments?post=1346"}],"version-history":[{"count":1,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1346\/revisions"}],"predecessor-version":[{"id":1348,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1346\/revisions\/1348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media\/1347"}],"wp:attachment":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media?parent=1346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/categories?post=1346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/tags?post=1346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}